Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Waranecki, Piotr
43  Ergebnisse:
Personensuche X
?
1

DIPG-51. DIFFUSE MIDLINE GLIOMAS HIJACK MYELOID CELL POPULA..:

Metselaar, Dennis Serge ; du Chatinier, Aimée ; Verbaan, Annemieke...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
2

The heterogeneous sensitivity of pediatric brain tumors to ..:

Vazaios, Konstantinos ; Stavrakaki, Εftychia ; Vogelezang, Lisette B....
Molecular Therapy: Oncology.  32 (2024)  2 - p. 200804 , 2024
Link: https://doi.org/10.1016/..
 
?
3

DIPG-21. PRECLINICAL ASSESSMENT OF A MULTIMODAL TREATMENT A..:

du Chatinier, Aimée ; Meel, Michaël H ; Waranecki, Piotr..
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
4

DIPG-75. PHARMACOLOGICAL INHIBITION OF LSD1/KDM1A IN DIFFUS..:

Hernandez, Faith A ; Stitzlein, Lea M ; Nam, Deokhwa...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Increased Bone Marrow Uptake and Accumulation of Very-Late ..:

Swart, Laura E. ; Fens, Marcel H. A. M. ; van Oort, Anita...
Pharmaceutics.  15 (2023)  6 - p. 1603 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Generation of immunocompetent syngeneic allograft mouse mod..:

du Chatinier, Aimée ; Meel, Michaël H ; Das, Arvid I...
Neuro-Oncology Advances.  4 (2022)  1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
7

MODL-16. Generation of immunocompetent syngeneic allograft ..:

du Chatinier, Aimée ; Meel, Michaël H ; Das, Arvid I...
Neuro-Oncology.  24 (2022)  Supplement_1 - p. i172-i172 , 2022
Link: https://doi.org/10.1093/..
 
?
8

AURKA and PLK1 inhibition selectively and synergistically b..:

Metselaar, Dennis S. ; du Chatinier, Aimée ; Meel, Michaël H....
iScience.  25 (2022)  6 - p. 104398 , 2022
Link: https://doi.org/10.1016/..
 
?
9

ATRT-18. SHH-SUBTYPE ATYPICAL TERATOID/RHABDOID TUMORS ARE ..:

Metselaar, Dennis ; Meel, Michaël Hananja ; Goulding, Joshua...
Neuro-Oncology.  22 (2020)  Supplement_3 - p. iii279-iii279 , 2020
Link: https://doi.org/10.1093/..
 
?
10

RONC-21. IDENTIFICATION OF EPIGENETIC DRUGS AS RADIOSENSITI..:

Metselaar, Dennis ; ter Huizen, Giovanna ; Meel, Michaël Hananja...
Neuro-Oncology.  22 (2020)  Supplement_3 - p. iii459-iii459 , 2020
Link: https://doi.org/10.1093/..
 
?
11

MEK/MELK inhibition and blood–brain barrier deficiencies in..:

Meel, Michaël H ; Guillén Navarro, Miriam ; de Gooijer, Mark C...
Neuro-Oncology.  22 (2019)  1 - p. 58-69 , 2019
Link: https://doi.org/10.1093/..
 
?
12

Celastrol-induced degradation of FANCD2 sensitizes pediatri..:

Metselaar, Dennis S. ; Meel, Michaël H. ; Benedict, Bente...
EBioMedicine.  50 (2019)  - p. 81-92 , 2019
Link: https://doi.org/10.1016/..
 
?
13

DIPG-05. PRECLINICAL EFFICACY OF MELK INHIBITION IN DIFFUSE..:

Meel, Michaël ; de Gooijer, Mark ; Navarro, Miriam Guillén...
Neuro-Oncology.  20 (2018)  suppl_2 - p. i49-i50 , 2018
Link: https://doi.org/10.1093/..
 
?
14

An efficient method for the transduction of primary pediatr..:

Meel, Michaël H. ; Metselaar, Dennis S. ; Waranecki, Piotr..
MethodsX.  5 (2018)  - p. 173-183 , 2018
Link: https://doi.org/10.1016/..
 
?
15

ATRT-19. PRECLINICAL EFFICACY OF COMBINED INHIBITION OF MEK..:

Meel, Michaël ; Navarro, Miriam Guillén ; de Gooijer, Mark...
Neuro-Oncology.  20 (2018)  suppl_2 - p. i31-i31 , 2018
Link: https://doi.org/10.1093/..
 
1-15